First-in-Human, Phase 1 Study of ADCE-T02, a Targeting Tissue Factor Antibody-Drug Conjugate, in Patients with Advanced Solid Tumors

  • Bhave, Prachi (Primary Chief Investigator (PCI))

Project: Research

Project Details

StatusActive
Effective start/end date7/11/24 → 7/11/26

Keywords

  • clinical trial
  • Solid Tumors
  • metastatic cancer
  • Targeting Tissue Factor Antibody-Drug Conjugate

Clinical Trial Phase

  • Phase I